0 results for ''Cadwalader Wickersham Taft''
Freshfields boosts US presence with Cadawalder corporate hire
Corporate partner Aly El Hamamsy joining magic circle firm's US teamCite as: Bldg Christopher LLC v. Herrick Feinstein LLP, 651795/12, NYLJ 1202772872695, at *1 (Sup., NY, Decided October 31, 2016) CASENAME Bldg Christopher LLC
No Asia Pullback for Baker & McKenzie
At a time when the Asia market becomes increasing challenging for global firms, some firms are choosing to retreat, but Baker & McKenzie's new Asia Pacific chair Gary Seib said his firm is more committed than ever.Cite as: BLDG Christopher v. Feinstein, 651795/12, NYLJ 1202772613392, at *1 (Sup., NY, Decided October 31, 2016)CASE NAMEBLDG Christopher LLC, LKDG Associates
'There will be lawsuits' – firms size up Trump impact on Asia business
Law firm leaders say post-election policy changes could result in more Asia workAfter Election, US Firms Ponder Asia Business
Law firms with large transactional and trade practices in Asia are waiting to see how many of President-elect Donald Trump's promises become reality.After Election, US Firms Ponder Asia Business
Law firms with large transactional and trade practices in Asia are waiting to see how many of President-elect Donald Trump's promises become reality.For DOJ Posts, Anti-Trump Sentiment Complicates Transition
Many lawyers who served in the last Republican administration have been openly critical of President-elect Donald Trump. Can there be conciliation?Law Office of J. Michael Hayes, Buffalo (J. Michael Hayes of Counsel), for Plaintiffs-Appellants.Hancock Estabrook, LLP, Syracuse (Alan J. Pierce of Counsel), for Defendant-Respondent
Patents for Computer and Life Science Technologies Making a Comeback?
Dorothy Auth and Howard Wizenfeld of Cadwalader, Wickersham & Taft examine two recent Federal Circuit cases regarding patent eligibility for computer- and life-science- related technologies. Many district court judges have dismissed cases based on patent ineligibility even before the claim language has been construed or any facts considered. Similarly, life science patents have been held invalid as covering laws of nature or natural phenomena. The recent decisions provide clues on how to draft claims that can survive a §101 challenge thereby allowing stakeholders to obtain and enforce patent claims that comport with the Supreme Court's jurisprudence under §101.Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now